Skip to main content
Top
Published in: European Archives of Oto-Rhino-Laryngology 2/2016

01-02-2016 | Laryngology

Th1-, Th2-, and Th17-associated cytokine expression in hypopharyngeal carcinoma and clinical significance

Authors: Xuemei Chen, Junfu Wang, Rui Wang, Qinghong Su, Junwen Luan, Haiyan Huang, Peng Zhou, Jinsheng Liu, Xiaoqun Xu

Published in: European Archives of Oto-Rhino-Laryngology | Issue 2/2016

Login to get access

Abstract

Th0 cells differentiate into Th1 or Th2 depending on multiple transcription factors acting on specific time points to regulate gene expression. Th17 cells, a subset of IL-17-producing T cells distinct from Th1 or Th2 cells, have been described as key players in inflammation and autoimmune diseases as well as cancer development. In the present study, 53 patients with hypopharyngeal cancer were included. The expression levels of Th1-, Th2- and Th17-associated cytokines in hypopharyngeal cancer tissues and pericarcinoma tissues were detected. The relationship between Th1, Th2, or Th17 infiltration and metastasis was studied. Our results showed that the mRNA and protein expressions of Th1 cytokines were lower, while the expressions of Th2 and Th17 cytokines were higher in tumor tissues, and the intensity of expression was strengthened with clinical stage increasing. Cancer tissues had higher level expressions of Th2 and Th17 cytokines than that of pericarcinoma tissues. From the above data, we speculated that high expressions of Th2- and Th17-associated cytokines in hypopharyngeal carcinoma may contribute to cancer development and metastasis.
Literature
1.
go back to reference Tosolini M, Kirilovsky A, Mlecnik B et al (2011) Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, Th2, Treg, Th17) in patients with colorectal cancer. Cancer Res 71:1263–1271PubMedCrossRef Tosolini M, Kirilovsky A, Mlecnik B et al (2011) Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, Th2, Treg, Th17) in patients with colorectal cancer. Cancer Res 71:1263–1271PubMedCrossRef
2.
go back to reference Su Z, Sun Y, Zhu H et al (2014) Th17 cell expansion in gastric cancer may contribute to cancer development and metastasis. Immunol Res 58:118–124PubMedCrossRef Su Z, Sun Y, Zhu H et al (2014) Th17 cell expansion in gastric cancer may contribute to cancer development and metastasis. Immunol Res 58:118–124PubMedCrossRef
3.
go back to reference Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454:436–444PubMedCrossRef Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454:436–444PubMedCrossRef
5.
go back to reference Hirahara K, Ghoreschi K, Laurence A, Yang XP, Kanno Y, O’Shea JJ (2010) Signal transduction pathways and transcriptional regulation in Th17 cell differentiation. Cytokine Growth Factor Rev 21:425–434PubMedPubMedCentralCrossRef Hirahara K, Ghoreschi K, Laurence A, Yang XP, Kanno Y, O’Shea JJ (2010) Signal transduction pathways and transcriptional regulation in Th17 cell differentiation. Cytokine Growth Factor Rev 21:425–434PubMedPubMedCentralCrossRef
6.
go back to reference Wei H, Sun R, Xiao W et al (2004) Type two cytokines predominance of human lung cancer and its reverse by traditional Chinese medicine TTMP. Cell Mol Immunol 1:63–70PubMed Wei H, Sun R, Xiao W et al (2004) Type two cytokines predominance of human lung cancer and its reverse by traditional Chinese medicine TTMP. Cell Mol Immunol 1:63–70PubMed
7.
go back to reference Dong C (2006) Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells. Nat Rev Immunol 6:329–333PubMedCrossRef Dong C (2006) Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells. Nat Rev Immunol 6:329–333PubMedCrossRef
8.
go back to reference Bettelli E, Carrier Y, Gao W et al (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441(7090):235–238PubMedCrossRef Bettelli E, Carrier Y, Gao W et al (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441(7090):235–238PubMedCrossRef
9.
go back to reference Yang XO, Pappu BP, Nurieva R et al (2008) T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 28:29–39PubMedPubMedCentralCrossRef Yang XO, Pappu BP, Nurieva R et al (2008) T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 28:29–39PubMedPubMedCentralCrossRef
11.
go back to reference Maruyama T, Kono K, Mizukami Y et al (2010) Distribution of Th17 cells and FoxP3(+) regulatory T cells in tumor-infiltrating lymphocytes, tumor-draining lymph nodes and peripheral blood lymphocytes in patients with gastric cancer. Cancer Sci 101:1947–1954PubMedCrossRef Maruyama T, Kono K, Mizukami Y et al (2010) Distribution of Th17 cells and FoxP3(+) regulatory T cells in tumor-infiltrating lymphocytes, tumor-draining lymph nodes and peripheral blood lymphocytes in patients with gastric cancer. Cancer Sci 101:1947–1954PubMedCrossRef
12.
go back to reference Gaur P, Singh AK, Shukla NK, Das SN (2014) Inter-relation of Th1, Th2, Th17 and Treg cytokines in oral cancer patients and their clinical significance. Hum Immunol 75:330–337PubMedCrossRef Gaur P, Singh AK, Shukla NK, Das SN (2014) Inter-relation of Th1, Th2, Th17 and Treg cytokines in oral cancer patients and their clinical significance. Hum Immunol 75:330–337PubMedCrossRef
13.
go back to reference Wrzesinski SH, Wan YY, Flavell RA (2007) Transforming growth factor-beta and the immune response: implications for anticancer therapy. Clin Cancer Res 13:5262–5270PubMedCrossRef Wrzesinski SH, Wan YY, Flavell RA (2007) Transforming growth factor-beta and the immune response: implications for anticancer therapy. Clin Cancer Res 13:5262–5270PubMedCrossRef
14.
go back to reference Jakowlew SB (2006) Transforming growth factor-beta in cancer and metastasis. Cancer Metastasis Rev 25:435–457PubMedCrossRef Jakowlew SB (2006) Transforming growth factor-beta in cancer and metastasis. Cancer Metastasis Rev 25:435–457PubMedCrossRef
15.
go back to reference Chen XM, Xu XQ, Sun K, Hallett WH, Zhao JD, Zhang DL (2008) NKG2D ligands expression and NKG2D-mediated cytotoxicity in human laryngeal squamous carcinoma cells. Scand J Immunol 67:441–447PubMedCrossRef Chen XM, Xu XQ, Sun K, Hallett WH, Zhao JD, Zhang DL (2008) NKG2D ligands expression and NKG2D-mediated cytotoxicity in human laryngeal squamous carcinoma cells. Scand J Immunol 67:441–447PubMedCrossRef
16.
go back to reference Maarof G, Bouchet-Delbos L, Gary-Gouy H, Durand-Gasselin I, Krzysiek R, Dalloul A (2010) Interleukin-24 inhibits the plasma cell differentiation program in human germinal center B cells. Blood 115:1718–1726PubMedCrossRef Maarof G, Bouchet-Delbos L, Gary-Gouy H, Durand-Gasselin I, Krzysiek R, Dalloul A (2010) Interleukin-24 inhibits the plasma cell differentiation program in human germinal center B cells. Blood 115:1718–1726PubMedCrossRef
17.
18.
go back to reference Hall SF, Groome PA, Irish J, O’Sullivan B (2008) The natural history of patients with squamous cell carcinoma of the hypopharynx. Laryngoscope 118:1362–1371PubMedCrossRef Hall SF, Groome PA, Irish J, O’Sullivan B (2008) The natural history of patients with squamous cell carcinoma of the hypopharynx. Laryngoscope 118:1362–1371PubMedCrossRef
19.
go back to reference Cooper JS, Porter K, Mallin K et al (2009) National Cancer Database report on cancer of the head and neck: 10-year update. Head Neck 31:748–758PubMedCrossRef Cooper JS, Porter K, Mallin K et al (2009) National Cancer Database report on cancer of the head and neck: 10-year update. Head Neck 31:748–758PubMedCrossRef
21.
go back to reference Takes RP, Strojan P, Silver CE et al (2012) Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery. Head Neck 34:270–281PubMedCrossRef Takes RP, Strojan P, Silver CE et al (2012) Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery. Head Neck 34:270–281PubMedCrossRef
22.
go back to reference Chan JY, Wei WI (2013) Current management strategy of hypopharyngeal carcinoma. Auris Nasus Larynx 40:2–6PubMedCrossRef Chan JY, Wei WI (2013) Current management strategy of hypopharyngeal carcinoma. Auris Nasus Larynx 40:2–6PubMedCrossRef
23.
24.
go back to reference Buckley JG, MacLennan K (2000) Cervical node metastases in laryngeal and hypopharyngeal cancer: a prospective analysis of prevalence and distribution. Head Neck 22:380–385PubMedCrossRef Buckley JG, MacLennan K (2000) Cervical node metastases in laryngeal and hypopharyngeal cancer: a prospective analysis of prevalence and distribution. Head Neck 22:380–385PubMedCrossRef
25.
go back to reference Kotwall C, Sako K, Razack MS, Rao U, Bakamjian V, Shedd DP (1987) Metastatic patterns in squamous cell cancer of the head and neck. Am J Surg 154:439–442PubMedCrossRef Kotwall C, Sako K, Razack MS, Rao U, Bakamjian V, Shedd DP (1987) Metastatic patterns in squamous cell cancer of the head and neck. Am J Surg 154:439–442PubMedCrossRef
26.
go back to reference Robson A (2002) Evidence-based management of hypopharyngeal cancer. Clin Otolaryngol Allied Sci 27:413–420CrossRef Robson A (2002) Evidence-based management of hypopharyngeal cancer. Clin Otolaryngol Allied Sci 27:413–420CrossRef
27.
go back to reference Allal AS (1997) Cancer of the pyriform sinus: trends towards conservative treatment. Bull Cancer 84:757–762PubMed Allal AS (1997) Cancer of the pyriform sinus: trends towards conservative treatment. Bull Cancer 84:757–762PubMed
28.
29.
go back to reference Mosmanm TR, Sad S (1996) The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17:138–146CrossRef Mosmanm TR, Sad S (1996) The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17:138–146CrossRef
31.
go back to reference Oshikawa K, Yanagisawa K, Ohno S, Tominaga S, Sugiyama Y (2002) Expression of ST2 in helper T lymphocytes of malignant pleural effusions. Am J Respir Crit Care Med 165:1005–1009PubMedCrossRef Oshikawa K, Yanagisawa K, Ohno S, Tominaga S, Sugiyama Y (2002) Expression of ST2 in helper T lymphocytes of malignant pleural effusions. Am J Respir Crit Care Med 165:1005–1009PubMedCrossRef
32.
go back to reference Chen YM, Yang WK, Whang-Peng J, Tasi CM, Perng RP (2001) An analysis of cytokine status in the serum and effusions of patients with tuberculous and lung cancer. Lung Cancer 31:25–30PubMedCrossRef Chen YM, Yang WK, Whang-Peng J, Tasi CM, Perng RP (2001) An analysis of cytokine status in the serum and effusions of patients with tuberculous and lung cancer. Lung Cancer 31:25–30PubMedCrossRef
33.
go back to reference Kharkevitch DD, Seito D, Balch GC, Maeda T, Balch CM, Itoh K (1994) Characterization of autologous-specific T-helper 2 cells in tumor-infiltrating lymphocytes from a patient with metastatic melanoma. Int J Cancer 58:317–323PubMedCrossRef Kharkevitch DD, Seito D, Balch GC, Maeda T, Balch CM, Itoh K (1994) Characterization of autologous-specific T-helper 2 cells in tumor-infiltrating lymphocytes from a patient with metastatic melanoma. Int J Cancer 58:317–323PubMedCrossRef
34.
go back to reference Chtanova T, Mackay CR (2001) T cell effector subsets: extending the Th1/Th2 paradigm. Adv Immunol 78:233–266PubMedCrossRef Chtanova T, Mackay CR (2001) T cell effector subsets: extending the Th1/Th2 paradigm. Adv Immunol 78:233–266PubMedCrossRef
35.
go back to reference Agarwal S, Misra R, Aggarwal A (2008) Interleukin 17 levels are increased in juvenile idiopathic arthritis synovial fluid and induce synovial fibroblasts to produce proinflammatory cytokines and matrix metalloproteinases. J Rheumatol 35(3):515–519PubMed Agarwal S, Misra R, Aggarwal A (2008) Interleukin 17 levels are increased in juvenile idiopathic arthritis synovial fluid and induce synovial fibroblasts to produce proinflammatory cytokines and matrix metalloproteinases. J Rheumatol 35(3):515–519PubMed
36.
go back to reference Gu Y, Hu X, Liu C, Qv X, Xu C (2008) Interleukin (IL)-17 promotes macrophages to produce IL-8, IL-6 and tumour necrosis factor-alpha in aplastic anaemia. Br J Haematol 142:109–114PubMedCrossRef Gu Y, Hu X, Liu C, Qv X, Xu C (2008) Interleukin (IL)-17 promotes macrophages to produce IL-8, IL-6 and tumour necrosis factor-alpha in aplastic anaemia. Br J Haematol 142:109–114PubMedCrossRef
37.
go back to reference Nabeshima K, Inoue T, Shimao Y, Sameshima T (2002) Matrix metalloproteinases in tumor invasion: role for cell migration. Pathol Int 52:255–264PubMedCrossRef Nabeshima K, Inoue T, Shimao Y, Sameshima T (2002) Matrix metalloproteinases in tumor invasion: role for cell migration. Pathol Int 52:255–264PubMedCrossRef
38.
go back to reference Li A, Dubey S, Varney ML, Dave BJ, Singh RK (2003) IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 170:3369–3376PubMedCrossRef Li A, Dubey S, Varney ML, Dave BJ, Singh RK (2003) IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 170:3369–3376PubMedCrossRef
39.
go back to reference Miyahara Y, Odunsi K, Chen W, Peng G, Matsuzaki J, Wang RF (2008) Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer. Proc Natl Acad Sci USA 105:15505–15510PubMedPubMedCentralCrossRef Miyahara Y, Odunsi K, Chen W, Peng G, Matsuzaki J, Wang RF (2008) Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer. Proc Natl Acad Sci USA 105:15505–15510PubMedPubMedCentralCrossRef
40.
go back to reference Zhang B, Rong G, Wei H et al (2008) The prevalence of Th17 cells in patients with gastric cancer. Biochem Biophys Res Commun 374:533–537PubMedCrossRef Zhang B, Rong G, Wei H et al (2008) The prevalence of Th17 cells in patients with gastric cancer. Biochem Biophys Res Commun 374:533–537PubMedCrossRef
41.
go back to reference Lee JJ, Chang YL, Lai WL et al (2011) Increased prevalence of interleukin-17-producing CD4(+) tumor infiltrating lymphocytes in human oral squamous cell carcinoma. Head Neck 33:1301–1308PubMedCrossRef Lee JJ, Chang YL, Lai WL et al (2011) Increased prevalence of interleukin-17-producing CD4(+) tumor infiltrating lymphocytes in human oral squamous cell carcinoma. Head Neck 33:1301–1308PubMedCrossRef
42.
go back to reference Chi LJ, Lu HT, Li GL et al (2010) Involvement of T helper type 17 and regulatory T cell activity in tumour immunology of bladder carcinoma. Clin Exp Immunol 161:480–489PubMedPubMedCentralCrossRef Chi LJ, Lu HT, Li GL et al (2010) Involvement of T helper type 17 and regulatory T cell activity in tumour immunology of bladder carcinoma. Clin Exp Immunol 161:480–489PubMedPubMedCentralCrossRef
43.
go back to reference Su X, Ye J, Hsueh EC, Zhang Y, Hoft DF, Peng G (2010) Tumor microenvironments direct the recruitment and expansion of human Th17 cells. J Immunol 184:1630–1641PubMedCrossRef Su X, Ye J, Hsueh EC, Zhang Y, Hoft DF, Peng G (2010) Tumor microenvironments direct the recruitment and expansion of human Th17 cells. J Immunol 184:1630–1641PubMedCrossRef
44.
go back to reference Wainwright DA, Sengupta S, Han Y, Ulasov IV, Lesniak MS (2010) The presence of IL-17A and T helper 17 cells in experimental mouse brain tumors and human glioma. PLoS One 5:e15390PubMedPubMedCentralCrossRef Wainwright DA, Sengupta S, Han Y, Ulasov IV, Lesniak MS (2010) The presence of IL-17A and T helper 17 cells in experimental mouse brain tumors and human glioma. PLoS One 5:e15390PubMedPubMedCentralCrossRef
45.
go back to reference Cantini G, Pisati F, Mastropietro A et al (2011) A critical role for regulatory T cells in driving cytokine profiles of Th17 cells and their modulation of glioma microenvironment. Cancer Immunol Immunother 60:1739–1750PubMedCrossRef Cantini G, Pisati F, Mastropietro A et al (2011) A critical role for regulatory T cells in driving cytokine profiles of Th17 cells and their modulation of glioma microenvironment. Cancer Immunol Immunother 60:1739–1750PubMedCrossRef
46.
go back to reference Zhou P, Sha H, Zhu J (2010) The role of T-helper 17 (Th17) cells in patients with medulloblastoma. J Int Med Res 38:611–619PubMedCrossRef Zhou P, Sha H, Zhu J (2010) The role of T-helper 17 (Th17) cells in patients with medulloblastoma. J Int Med Res 38:611–619PubMedCrossRef
Metadata
Title
Th1-, Th2-, and Th17-associated cytokine expression in hypopharyngeal carcinoma and clinical significance
Authors
Xuemei Chen
Junfu Wang
Rui Wang
Qinghong Su
Junwen Luan
Haiyan Huang
Peng Zhou
Jinsheng Liu
Xiaoqun Xu
Publication date
01-02-2016
Publisher
Springer Berlin Heidelberg
Published in
European Archives of Oto-Rhino-Laryngology / Issue 2/2016
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-015-3779-2

Other articles of this Issue 2/2016

European Archives of Oto-Rhino-Laryngology 2/2016 Go to the issue